Software acceleration for existing hardware. You have 500 videos to transcode. You don’t sit down and write a parallel execution plan from scratch. You run one line: python wpc-recipe.py ffmpeg-h264 .videos …and out comes videos.plan.wpc.txt — one tuned command per file, ready to feed straight to WonderPhi Compute, which runs them across every core you […]
content by LCUS
Case Study — WonderPhi Compute Burn-In on a Dual-Xeon Workstation
Software acceleration for existing hardware. Theory is cheap. We measured WonderPhi Compute on real hardware — a workstation with dual Intel Xeon Gold 6138T processors (40 physical cores, 80 logical), an NVIDIA A10M GPU with 19 GB of VRAM, running Windows 11 Pro. Every number below is wall-clock time, single run, cold cache. No averaging. […]
WonderPhi Compute — Put the Compute Back in the Game
Software acceleration for existing hardware. Every machine you own has more power than you use. Cores sit idle. GPU memory stays dark. Background processes eat cycles you never asked them to. The operating system has its own agenda, and your work waits in line behind it. WonderPhi Compute is the antidote: a constitutional parallel runner […]
Case Study – A University Lab Runs a Pilot-Scale Nuclear Recycling Program Without a Full-Scale Budget
[lcus_masonry_article] Case Study: A University Lab Runs a Pilot-Scale Nuclear Recycling Program Without a Full-Scale Budget A university engineering department with ties to national nuclear R&D had a mandate to train personnel and validate microwave-enhanced waste processing at pilot scale. They did not have budget or site for a full-scale facility; they needed a compact […]
Case Study – A Regional Operator Turns a Landfill into a Multi-Revenue Resource Site
[lcus_masonry_article] Case Study: A Regional Operator Turns a Landfill into a Multi-Revenue Resource Site A regional waste and recycling operator managed a capped landfill with no active recovery. Regulations were tightening; they were under pressure to show resource recovery and revenue diversification. Fixed-plant recycling was not feasible for the site; they needed a mobile solution […]
Case Study – A Foundry R&D Group Shortens Material Discovery with a Ranked Database and a Top Candidate
[lcus_masonry_article] Case Study: A Foundry R&D Group Shortens Material Discovery with a Ranked Database and a Top Candidate A foundry’s materials R&D group was under pressure to identify a next-generation semiconductor material that could meet performance, thermal, and cost targets. Internal efforts had produced a long list of candidates but no clear “lead” with full […]
Case Study – A Mid-Tier Pharma Uses a 300-Disease Package to Prioritize and Out-License
[lcus_masonry_article] Case Study: A Mid-Tier Pharma Uses a 300-Disease Package to Prioritize and Out-License A mid-tier pharmaceutical company wanted to expand its early pipeline without running 300 separate discovery programs. They were interested in a single, structured research package that covered many indications with a consistent methodology—compound analysis, synthesis methods, biological mechanism documentation—so they could […]
Case Study – A Pharma Partner Licenses the Parkinson’s Cure Discovery Package for Pipeline
[lcus_masonry_article] Case Study: A Pharma Partner Licenses the Parkinson’s Cure Discovery Package for Pipeline A pharmaceutical company with a strong CNS pipeline was looking for a cure-focused Parkinson’s asset—not another symptomatic therapy—that came with a clear discovery report, methodology, compound analysis, and synthesis pathways. They had the development and regulatory capacity; they needed a defined […]
Case Study – A Biotech Evaluates the Alzheimer’s Cure Discovery for a Multi-Mechanism Program
[lcus_masonry_article] Case Study: A Biotech Evaluates the Alzheimer’s Cure Discovery for a Multi-Mechanism Program A biotech focused on neurodegenerative disease wanted to expand beyond amyloid-only approaches. They were interested in a research package that targeted Alzheimer’s through multiple mechanisms—amyloid, tau, neuroinflammation, neuronal regeneration—with a consistent methodology and documentation suitable for partnership and regulatory planning. They […]
Case Study – A Diabetes-Focused Partner Uses the Cure Discovery to De-Risk Lead Selection
[lcus_masonry_article] Case Study: A Diabetes-Focused Partner Uses the Cure Discovery to De-Risk Lead Selection A company with a diabetes and metabolic pipeline was looking for cure-focused compounds—not another glucose management asset—with validated discovery scores, synthesis methods, and scientific evidence aligned with known mechanisms (e.g. zinc–amino acid complexes, insulin signaling). They had development capacity; they needed […]